# Montelukast and Fexofenadine Versus Montelukast and Levocetrizine Combination in Allergic Rhinitis

> **NCT02551536** · PHASE4 · COMPLETED · sponsor: **Indira Gandhi Medical College, Shimla** · enrollment: 70 (actual)

## Conditions studied

- Allergic Rhinitis

## Interventions

- **DRUG:** Montelukast
- **DRUG:** Fexofenadine
- **DRUG:** Levocetrizine

## Key facts

- **NCT ID:** NCT02551536
- **Lead sponsor:** Indira Gandhi Medical College, Shimla
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2015-04
- **Final completion:** 2015-06
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2015-09-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02551536

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02551536, "Montelukast and Fexofenadine Versus Montelukast and Levocetrizine Combination in Allergic Rhinitis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02551536. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
